Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing Sarcoma.
Puerto-Camacho P, Amaral AT, Lamhamedi-Cherradi SE, Menegaz BA, Castillo-Ecija H, Ordóñez JL, Domínguez S, Jordan-Perez C, Diaz-Martin J, Romero-Pérez L, Lopez-Alvarez M, Civantos-Jubera G, Robles-Frías MJ, Biscuola M, Ferrer C, Mora J, Cuglievan B, Schadler K, Seifert O, Kontermann R, Pfizenmaier K, Simón L, Fabre M, Carcaboso ÁM, Ludwig JA, de Álava E. Puerto-Camacho P, et al. Among authors: ferrer c. Clin Cancer Res. 2019 Apr 1;25(7):2228-2240. doi: 10.1158/1078-0432.CCR-18-0936. Epub 2018 Nov 12. Clin Cancer Res. 2019. PMID: 30420447 Free PMC article.
OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models.
Fabre M, Ferrer C, Domínguez-Hormaetxe S, Bockorny B, Murias L, Seifert O, Eisler SA, Kontermann RE, Pfizenmaier K, Lee SY, Vivanco MD, López-Casas PP, Perea S, Abbas M, Richter W, Simon L, Hidalgo M. Fabre M, et al. Among authors: ferrer c. Clin Cancer Res. 2020 Jul 1;26(13):3420-3430. doi: 10.1158/1078-0432.CCR-19-2238. Epub 2020 Mar 11. Clin Cancer Res. 2020. PMID: 32161121
Targeting carcinoma-associated mesothelial cells with antibody-drug conjugates in ovarian carcinomatosis.
Pascual-Antón L, Sandoval P, González-Mateo GT, Kopytina V, Tomero-Sanz H, Arriero-País EM, Jiménez-Heffernan JA, Fabre M, Egaña I, Ferrer C, Simón L, González-Cortijo L, Sainz de la Cuesta R, López-Cabrera M. Pascual-Antón L, et al. Among authors: ferrer c. J Pathol. 2023 Oct;261(2):238-251. doi: 10.1002/path.6170. Epub 2023 Aug 9. J Pathol. 2023. PMID: 37555348
In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma.
Pérez-Salvia M, Aldaba E, Vara Y, Fabre M, Ferrer C, Masdeu C, Zubia A, Sebastian ES, Otaegui D, Llinàs-Arias P, Rosselló-Tortella M, Berdasco M, Moutinho C, Setien F, Villanueva A, González-Barca E, Muncunill J, Navarro JT, Piris MA, Cossio FP, Esteller M. Pérez-Salvia M, et al. Among authors: ferrer c. Haematologica. 2018 Nov;103(11):e537-e540. doi: 10.3324/haematol.2018.189241. Epub 2018 Jun 7. Haematologica. 2018. PMID: 29880608 Free PMC article. No abstract available.
EFFICACY AND SAFETY OF BIOLOGICAL TREATMENT FOR INFLAMMATORY BOWEL DISEASE IN ELDERLY PATIENTS: RESULTS FROM A GETECCU COHORT.
Ferrer CS, Gismero FM, Caballol B, Ballester MP, Rey IB, García AC, Bautista JM, Chumillas RS, Benitez JM, Delgado LS, García AL, de Celix CR, Abreu IA, Melcarne L, Santos RP, Camí MM, Mateos AC, Díez CG, Calafat M, Galan HA, Vilaamil PV, Senosiain BC, Moya AG, Rodriguez Diaz CY, Spicakova K, Marcos NM, Molina G, Castro Parga L, Angulo AR, Del Campo LC, Rodriguez Grau MDC, Ramirez F, Pastrana BG, Partida IG, Mateu BB, Gonzalez EP, Iyo E, Gonzalez AE, Arnau ES, Villalba LH, Galindo PP, Medina LT, Alonso SM, Olmos Perez JA, Sadornil CD, Ramirez LG, Martín-Arranz MD, Sanroman AL, Fernández A, Murgui VM, Suárez CC, Florez P, Lobato Matilla ME, Sicilia B, Escribano PS, Martin CM, Mañosa M, De Acosta MB; On belhaf of Young group of GETECCU. Ferrer CS, et al. Gastroenterol Hepatol. 2024 May 4:502197. doi: 10.1016/j.gastrohep.2024.502197. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38710465 English, Spanish.
A Core Outcome Set for Intact Abdominal Aortic Aneurysm Repair.
Machin M, Wanhainen A, D'Oria M, Koelemaij M, Kakkos S, Grima MJ, Powell JT; collaborators. Machin M, et al. Eur J Vasc Endovasc Surg. 2024 Apr 25:S1078-5884(24)00365-4. doi: 10.1016/j.ejvs.2024.04.029. Online ahead of print. Eur J Vasc Endovasc Surg. 2024. PMID: 38677466 Free article.
Outcomes of Off the Shelf Outer Branched Versus Inner Branched Endografts in the Treatment of Thoraco-abdominal Aortic Aneurysm in the B.R.I.O. (BRanched Inner - Outer) Study Group.
Piazza M, Squizzato F, Pratesi G, Parlani G, Simonte G, Giudice R, Mansour W, Veraldi GF, Gennai S, Antonello M; B.R.I.O. (BRanched Inner – Outer) Investigators. Piazza M, et al. Eur J Vasc Endovasc Surg. 2024 Apr 16:S1078-5884(24)00341-1. doi: 10.1016/j.ejvs.2024.04.005. Online ahead of print. Eur J Vasc Endovasc Surg. 2024. PMID: 38636923 Free article.
Early and midterm results of covered balloon-expandable stents (VBX-Gore) for endovascular treatment of chronic aorto-iliac occlusion.
Mezzetto L, D'Oria M, Gallitto E, Troisi N, Ferrer C, Zanetti E, Grando B, Mastrorilli D, Giudice R, Berchiolli R, Gargiulo M, Lepidi S, Veraldi GF. Mezzetto L, et al. Among authors: ferrer c. J Cardiovasc Surg (Torino). 2024 Apr 15. doi: 10.23736/S0021-9509.24.12977-1. Online ahead of print. J Cardiovasc Surg (Torino). 2024. PMID: 38618697
The Influence of Surgical Complexity and Center Experience on Postoperative Morbidity After Minimally Invasive Surgery in Gynecologic Oncology: Lessons Learned from the ROBOGYN-1004 Trial.
Lambaudie E, Bogart E, Le Deley MC, El Hajj H, Gauthier T, Hebert T, Collinet P, Classe JM, Lecuru F, Motton S, Conri V, Ferrer C, Marchal F, Ferron G, Probst A, Jauffret C, Narducci F. Lambaudie E, et al. Among authors: ferrer c. Ann Surg Oncol. 2024 Apr 15. doi: 10.1245/s10434-024-15265-1. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38616209
400 results